Comparison of the medication adherence of patients treated with telmisartan/hydrochlorothiazide or telmisartan/amlodipine FDC versus double-pill combination therapy in real-world Japanese therapeutic practice

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/29656
• EU PAS number:
  EUPAS19696
• Study ID:
  29656
• Official title and acronym:
  Comparison of the medication adherence of patients treated with telmisartan/hydrochlorothiazide or telmisartan/amlodipine FDC versus double-pill combination therapy in real-world Japanese therapeutic practice
• DARWIN EU® study:
  No
• Study countries:
  Japan
• Study description:
  This is a retrospective, observational study in Japanese patients with hypertension based on Japanese prescription database. The primary objective of this study is to compare the medication adherence measured by PDC of patients with FDC or double-pill combination therapy in real-world Japanese therapeutic practice. The further objective of this study is how much influence the background of patients to the adherence.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Boehringer Ingelheim

Study timelines

Date when funding contract was signed

Planned: 20/06/2017

Actual: 30/06/2017

Study start date

Planned: 18/01/2018

Actual: 11/01/2018

Date of final study report

Planned: 29/03/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Nippon Boehringer Ingelheim Co., Ltd.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable